Abstract Submission and Poster Guidelines

Abstract Submission

OPEN ABSTRACT SUBMISSION

April 1

DEADLINE FOR ABSTRACT SUBMISSION

July 31st

NOTIFICATION OF ACCEPTANCE

September 16th

VÍDEO SUBMISSION DEADLINE 

October 10th

  • Requirements for authors: the corresponding author must have a valid registration to the event (payment is not required at this stage).
  • The abstract should be written in English.
  • Abstracts per registration: 1 (one)
  • The abstract category which best describes the subject of the abstract should be chosen.
  • Notification of acceptance will be sent to the submitting (corresponding) author until September 15th.
  • If your abstract is selected you should upload a 4-6 min video in English to the poster submission site. The deadline to submit your vídeo is October 10th.
  • A small number of highest-scoring abstracts will be selected for presentation in oral presentation sessions.
  • Authors must state the Thematic Area in wich they wish to present their abstract at the time of submission.
  • The thematic areas (topics) are:

 

  1. Nanotechnology
  2. Food and Nutrition Sciences
  3. Pharmaceutical Care, Clinical Pharmacy and Patient Safety
  4. Biochemistry, Molecular Biology and Genetics
  5. Biotechnology and Clinical Analysis
  6. Pharmacology, Physiology and Toxicology
  7. Bioinformatics and Molecular Modelling
  8. Physics and Biological Chemistry
  9. Education and Management in Pharmaceutical Sciences
  10. Parasitology, Microbiology and Immunology
  11. Natural and Synthetic Products
  12. Medicinal Chemistry
  13. Pharmaceutical and Cosmetic Technology
  14. Pharmacoepidemiology, Pharmacoeconomics and Marketing

 

The CIFARP 2021 Virtual Meeting accepted abstracts will be published in a special electronic issue of the journal Biomedical and Biopharmaceutical Research. The publication of the abstract will be optional, under consent of the authors.

Authors interested in publishing the abstract approved in CIFARP 2021 must send the abstract to the e-mail comissaocifarp@fcfrp.usp.br in accordance with the rules of the BBR journal as described below

 

Journal Biomedical and Biopharmaceutical Research (BBR)

Jornal de Investigação Biomédica e Biofarmacêutica

2182-2360 (PRINT) / 2182-2379 (ONLINE)

There are NO PUBLICATION FEES

(article processing charges or APCs) to publish with this journal.

 

Guidelines for Authors

This Journal is dedicated to publish and therefore, to promote knowledge and views on questions associated with Health, giving priority to those related to the Portuguese reality, as well as those in other lusophone (Portuguese speaking) communities. The intention therefore is to catalyze a productive dialogue and exchange of experiences between researchers and health professionals and from the lusophone communities and their projection on, and interchange with the international scientific community.

In order to attain such objectives, it has become indispensable to establish, since the beginning, a set of norms that guarantee a publication which respects the internationally established criteria for publications in the biomedical field. The main norms, which have been adapted to the above mentioned objectives, have the document “Uniform Requirements for Manuscripts Submitted you the Biomedical Journals” (available at URL: www.icmje.org) as their main orientation and are as follows:

I. The “Biomedical and Biopharmaceutical Research” (BBR) publishes original research, as well as other works of a pedagogical and scientific nature, in the main domains of Health Sciences.

II. It also publishes news, information, minutes, and/or reports, as well as abstracts and proceedings of works presented in meetings, courses, or congresses.

III. The authors have the final responsibility for the content of their publications.

IV. All published articles become the property of the BBR. Once accepted, articles cannot be published in a similar form in other places, and in any other language, without the express consent of the BBR. If the manuscript was previously posted to a community preprint server, it should be updated with a link to the final published version.

V. The periodicity of this Journal is semi-annual, and the dates of submission and publication should be consulted in the respective portal. Depending on the Editorial initiative, other numbers might be edited along the semester.

IV. Before submitting a manuscript or abstract to BBR, authors must obtain all necessary authorizations for the submitted material to be published, and when applicable, according the publication norms from the journal. 

Manuscript Format

(a) All abstracts from CIFARP 2021 must be submitted in English. The abstracts must be typed, double spaced and aligned at the left, with margins of 2.5 cm, font size 11, in font Times, Times New Roman, or Arial, and use Symbol for special characters

– Abstracts – maximum of 200 words. Each abstract will contain, on the same page, the respective keywords (up to five).

Abstract template:

 

DEVELOPMENT OF AN IN VITRO TEST FOR THE EVALUATION OF NEW PHYTOTERAPICS

João Silva (Brasil)1; Rita Silva (Brasil)1; José Almeida (Brasil)2

1 Laboratório de Reprodução Assistida, Faculdade de Farmácia de XXXXX.

2 Centro de Pesquisa e Investigação Avançada, Faculdade de Biotecnologia de XXXXXX.

Key words: XXXXXXXXXXX, XXXXXXXXXXXXX, XXXXXXXX, XXXX. 

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX (200 words).